Journal of Stem Cells & Regenerative Medicine

Scope & Guideline

Connecting Knowledge to Practice in Regenerative Medicine

Introduction

Welcome to the Journal of Stem Cells & Regenerative Medicine information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Journal of Stem Cells & Regenerative Medicine, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0973-7154
PublisherJOURNAL STEM CELLS & REGENERATIVE MEDICINE
Support Open AccessYes
CountryIndia
TypeJournal
Convergefrom 2010 to 2024
AbbreviationJ STEM CELLS REGEN / J. Stem Cells Regen. Med.
Frequency2 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressJOURNAL STEM CELLS & REGENERATIVE MEDICINE, CHENNAI 00000, INDIA

Aims and Scopes

The Journal of Stem Cells & Regenerative Medicine is dedicated to advancing the understanding and application of stem cell biology and regenerative therapies. The journal encompasses a wide range of topics that explore the mechanisms, applications, and innovations in stem cell research.
  1. Stem Cell Biology and Mechanisms:
    Focuses on the fundamental biology of various stem cell types, including their differentiation pathways, signaling mechanisms, and the molecular underpinnings that govern stem cell behavior.
  2. Regenerative Medicine Applications:
    Covers research on the therapeutic applications of stem cells in regenerative medicine, including tissue engineering, wound healing, and organ repair.
  3. Cell Therapy Innovations:
    Explores advancements in cell therapy techniques, including the use of mesenchymal stem cells (MSCs) and their derivatives for treating various medical conditions.
  4. Extracellular Vesicles and Secretomes:
    Investigates the role of stem cell-derived extracellular vesicles and secretomes in mediating therapeutic effects and their potential as cell-free therapies.
  5. Clinical Trials and Safety Studies:
    Includes clinical research and trials assessing the safety and efficacy of stem cell therapies, emphasizing translational research from bench to bedside.
Recent publications in the Journal of Stem Cells & Regenerative Medicine indicate a shift towards several trending and emerging themes that reflect current advancements and interests in the field.
  1. Exosome and Secretome Research:
    There is a growing emphasis on the therapeutic potential of exosomes and secretomes derived from stem cells, highlighting their use as cell-free therapies and their role in mediating regenerative effects.
  2. Cancer Stem Cells and Metastasis:
    Research on cancer stem cells, particularly their role in tumor metastasis and treatment resistance, is gaining traction, reflecting the need for innovative approaches to cancer therapy.
  3. Personalized Medicine Approaches:
    The integration of personalized medicine in stem cell therapies, considering donor characteristics and patient-specific factors, is emerging as a significant theme in recent studies.
  4. Regenerative Strategies for Specific Conditions:
    Increasingly, the journal features studies on targeted regenerative strategies for specific conditions, such as osteoarthritis and urethral strictures, showcasing a shift towards tailored therapeutic interventions.
  5. Gut-Brain Axis and Stem Cells:
    Research connecting the gut microbiome and gut-brain axis with stem cell therapy is on the rise, indicating an interdisciplinary approach to understanding health and disease.

Declining or Waning

While certain areas of focus remain robust, some themes within the Journal of Stem Cells & Regenerative Medicine appear to be declining in prominence. This suggests a potential shift in research interests or methodological approaches.
  1. Traditional Stem Cell Sources:
    Research on traditional sources of stem cells, such as embryonic stem cells, has seen a decline in favor of more innovative and ethically acceptable sources, such as induced pluripotent stem cells (iPSCs) and adult-derived stem cells.
  2. Basic Preclinical Studies:
    There is a noticeable reduction in purely basic preclinical studies, as the journal increasingly emphasizes translational research that directly connects laboratory findings to clinical applications.
  3. Single Cell Studies:
    Research focusing on single cell analysis within stem cell populations is becoming less frequent, possibly due to the rising interest in bulk analysis methods and population-level characteristics.
  4. Non-therapeutic Stem Cell Research:
    Interest in non-therapeutic investigations of stem cells, such as purely developmental biology studies without direct clinical implications, appears to be waning.

Similar Journals

Cell Journal

Unlocking the Secrets of Life at the Cellular Level
Publisher: ROYAN INSTISSN: 2228-5806Frequency: 12 issues/year

Cell Journal is a leading interdisciplinary publication in the fields of Cell Biology, Developmental Biology, Molecular Biology, and Reproductive Medicine, published by ROYAN INST since its inception as an open-access journal in 2007. With an ISSN of 2228-5806 for print and 2228-5814 for electronic editions, it provides a vital platform for researchers and professionals to disseminate innovative findings and insights that shape our understanding of cellular processes and reproductive sciences. The journal boasts an impressive Scopus ranking, achieving a Q3 position in both Molecular Biology and Reproductive Medicine, highlighting its significance in the academic community. Situated in Tehran, Iran, Cell Journal encourages global collaboration through its accessible content, making cutting-edge research available to a diverse audience. As it converges from 2011 to 2024, the journal continues to emphasize the importance of thorough scientific inquiry, fostering advancements that drive both theoretical frameworks and practical applications in cell science.

Tissue Engineering and Regenerative Medicine

Pioneering Solutions in Tissue Restoration and Repair
Publisher: KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOCISSN: 1738-2696Frequency: 6 issues/year

Tissue Engineering and Regenerative Medicine, published by the Korean Tissue Engineering Regenerative Medicine Society, is a distinguished journal focusing on the interdisciplinary fields of tissue engineering, regenerative medicine, and related biomedical innovations. With an ISSN of 1738-2696 and an E-ISSN of 2212-5469, this journal disseminates cutting-edge research and advancements pivotal to developing therapeutic strategies that improve tissue function and repair. As a testament to its scholarly impact, it holds a Q2 ranking in both Biomedical Engineering and Medicine (miscellaneous) categories, reflecting its influence and relevance within the scientific community, particularly with a Scopus rank placing it in the 82nd percentile among similar journals. Although the journal does not offer open access, it provides vital insights and knowledge to researchers, professionals, and students involved in the quest for innovative solutions in medical science and engineering. With its convergence years extending from 2008 to 2024, the journal continues to be an essential platform for the dissemination of high-quality research that drives the field forward.

BIOCELL

Connecting Researchers for a Deeper Understanding of Life Sciences
Publisher: TECH SCIENCE PRESSISSN: 0327-9545Frequency: 12 issues/year

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

CYTOTECHNOLOGY

Transforming Knowledge: Your Gateway to Cutting-Edge Cytotechnological Research.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

Stem Cells Translational Medicine

Empowering Researchers in the Stem Cell Revolution
Publisher: OXFORD UNIV PRESSISSN: 2157-6564Frequency: 12 issues/year

Stem Cells Translational Medicine, published by Oxford University Press, is a leading open-access journal that has been at the forefront of stem cell research since its launch in 2012. With an impressive impact across various categories, it occupies Q2 in Cell Biology and is highly recognized in Q1 for both Developmental Biology and Miscellaneous Medicine in 2023. Its strong Scopus rankings highlight its significance in the fields of Biochemistry, Genetics, and Molecular Biology, achieving an outstanding percentile ranking of 93rd in Developmental Biology. The journal provides a pivotal platform for researchers, professionals, and students to publish and access cutting-edge findings that contribute to the understanding and application of stem cell technology. With a commitment to disseminating high-quality scientific knowledge, Stem Cells Translational Medicine plays a vital role in advancing research and innovation within the rapidly evolving landscape of regenerative medicine.

Cells

Illuminating the World of Cells Through Groundbreaking Research
Publisher: MDPIISSN: Frequency: 24 issues/year

Cells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.

Inflammation and Regeneration

Fostering collaboration for a healthier tomorrow through science.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

Current Stem Cell Research & Therapy

Bridging Research and Therapy in Stem Cell Innovation
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1574-888XFrequency: 8 issues/year

Current Stem Cell Research & Therapy, published by Bentham Science Publishers Ltd, is a leading journal dedicated to advancing the field of stem cell research. With an ISSN of 1574-888X and an E-ISSN of 2212-3946, this journal has been a valuable resource since its inception in 2006 and continues to broaden its scope through 2024. Recognized in the Q2 quartile for Medicine (miscellaneous) and ranked in the 66th percentile among its peers, the journal plays a crucial role in disseminating high-quality, peer-reviewed research that explores both the therapeutic and biological implications of stem cells. Located in the United Arab Emirates, Current Stem Cell Research & Therapy embraces a global audience of researchers, professionals, and students, providing a vibrant platform for discourse and innovation. While the journal offers subscription-based access, it remains committed to enhancing the scientific community's understanding of stem cell therapy and its applications across various medical fields.

Organogenesis

Transforming Understanding in Regenerative Medicine.
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6278Frequency: 4 issues/year

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

Asian Journal of Pharmaceutical Sciences

Connecting global minds through open-access pharmaceutical research.
Publisher: SHENYANG PHARMACEUTICAL UNIVISSN: 1818-0876Frequency: 6 issues/year

Asian Journal of Pharmaceutical Sciences is a prestigious open-access journal published by Shenyang Pharmaceutical University, dedicated to advancing research and developments in the field of pharmaceutical sciences. Since its inception in 2009, the journal has successfully converged a wealth of knowledge and innovation, demonstrating an impressive track record with its open access model adopted in 2013, ensuring global dissemination of crucial research findings. With an outstanding impact factor and consistently ranked in the Q1 category for both Pharmaceutical Science and Pharmacology in 2023, it ranks among the top journals in its field, as evidenced by its impressive Scopus rankings—4th out of 183 in Pharmaceutical Science and 10th out of 313 in Pharmacology, showcasing its high relevance and credibility (98th and 96th percentiles respectively). Researchers, professionals, and students can access a diverse array of articles that encompass groundbreaking studies, reviews, and reports, solidifying the journal's position as a vital resource for anyone engaged in pharmaceutical research. With its commitment to quality and accessibility, Asian Journal of Pharmaceutical Sciences plays an essential role in fostering innovation and collaboration within the global scientific community.